ABSTRACT
Introduction The pain associated with lower extremity arterial disease is difficult to treat, even with lower extremity revascularization. We sought to evaluate in-hospital and post-operative opioid usage in patients with different disease severities and treatments for lower extremity vascular disease.
Methods A retrospective review was performed for all hospital encounters for patients with an International Classification of Diseases (ICD) code consistent with lower extremity arterial disease admitted to single center between January 2018 and March 2023. Encounters were subdivided according to patient’s disease severity, treatment type as designated by Current Procedural Terminology (CPT) code and comorbid diagnosis of diabetes mellitus. These groups were analyzed for in-hospital opioid use frequency and dosage. Encounters for patients admitted with a secondary diagnosis of lower extremity atherosclerotic disease were included as the control group (CON). A total of 438 patients represented by all the analyzed encounters were then reviewed for number and type of vascular procedures performed as well as opioid use in the outpatient setting for one year.
Results Critical limb ischemia (CLI) encounters were more likely to use opioids as compared CON and peripheral arterial disease (PAD) without rest pain, ulcer or gangrene groups (CLI 67.9% versus CON 52.1%, p < 0.001 and CLI 67.9% versus PAD 50.2%, p < 0.001). Opioid use was also more common in encounters for gangrene and groups treated with revascularization (REVASC) and amputation (AMP) as compared to CON (gangrene 74.5% versus CON 52.1%, p < 0.01; REVASC 58.3% versus CON 52.1%, p =0.01; and AMP 72.3% versus CON 52.1%, p < 0.01). Significantly increased opioid doses per day (MME/day) were not noted for any of the investigated groups as compared to CON. In the outpatient setting, 186 (42.5%) patients were using opioids one month after the most recent vascular intervention. By one year, 31 (7.1%) patients were still using opioids. No differences in opioid usage were noted for patients undergoing single versus multiple vascular interventions at one year. Patients undergoing certain vascular surgery procedures were more likely to be using opioids at one year.
Conclusion Patients with CLI and gangrene as well as those undergoing vascular treatment have a greater frequency of opioid use during hospital encounters as compared those patients with less severe disease and undergoing conservative management, respectively. However, these findings do not equate to higher doses of opioid used during hospitalization. Patients undergoing multiple vascular procedures are not more likely to be using opioid long-term (at one year) as compared to those patients treated with single vascular procedures.
Type of Research A single-center, retrospective review
Key Findings Patients with critical limb ischemia during hospitalization use opioids more frequently than patients with less severe vascular disease. These findings do not equate to higher doses of opioid used during hospitalization. Patients with lower extremity arterial disease undergoing multiple vascular procedures are not more likely to be using opioids long-term (at one year) as compared to patients treated with single vascular procedures.
Take Home Message The pain associated with lower extremity arterial occlusive disease often requires treatment with opioids, however, disease severity and numerous treatments do not equate with the need for increased or prolonged dosage.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Permission for this retrospective review was granted by the Penn State College of Medicine Institutional Review Board, IRB protocol 22745.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript